Neumora Therapeutics, Inc. (NMRA) — Tangible Net Worth Ratio
Neumora Therapeutics, Inc. (NMRA) has a Tangible Net Worth Ratio of 100.0% as of September 2025. This metric is calculated by deducting intangible assets ($0.00) from net assets ($132.16 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Neumora Therapeutics, Inc. equity growth rate to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Neumora Therapeutics, Inc. Tangible Net Worth Ratio (2023–2024)
This chart shows how Neumora Therapeutics, Inc.'s Tangible Net Worth Ratio has changed across 2 annual periods from 2023 to 2024. As of September 2025, the ratio stands at 100.0%, reflecting net assets of $132.16 Million with intangible assets of $0.00 USD. For live market cap and overall valuation, see Neumora Therapeutics, Inc. (NMRA) total market value.
Annual Tangible Net Worth Ratio for Neumora Therapeutics, Inc. (2023–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Neumora Therapeutics, Inc. from 2023 to 2024, covering 2 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. See NMRA free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 100.0% | $287.06 Million | $0.00 | $316.97 Million | ▲ +0.0 pp |
| 2023 | 100.0% | $469.08 Million | $0.00 | $496.19 Million | — |